Generation Bio Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$100M
Industry:Biotech
Founded:2016
Lead Investor(s):Fidelity Management & Research Company
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Generation Bio's estimated annual revenue is currently $16M per year.
  • Generation Bio received $100.0M in venture funding in February 2018.
  • Generation Bio's estimated revenue per employee is $155,000
  • Generation Bio's total funding is $100M.

Employee Data

  • Generation Bio has 103 Employees.
  • Generation Bio grew their employee count by 18% last year.
  • Generation Bio currently has 8 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ultivue
$8.7M56-12%N/A
Ohana Bioscienc...
$8.7M5660%N/A
Compass Therape...
$16.4M10614%N/A
Cell Signaling ...
$89.4M577N/AN/A
Momenta Pharmac...
N/A220N/AN/A
Emulate
$15.3M99-17%N/A
ArQule
N/A94N/AN/A
Hamilton Storag...
$17.2M1119%N/A
Alnylam Pharmac...
$74.9M127731%N/A
Transgenomic
N/A47N/AN/A
Missing a competitor? Contribute!?
Submit

Generation Bio is creating a revolutionary new class of genetic medicines that deliver durable, high levels of gene expression and have drug-like properties, including ability to titrate to effect and re-dose. Our unique GeneWave technology allows us to overcome the limitations of other approaches by delivering larger genes, including more sophisticated regulatory elements, and avoiding the immunogenicity which limits both the number of patients who can be treated and the ability to re-dose them over time. We are a community of creative problem-solvers and independent thinkers. We are guided by strong personal integrity, humility, and the collaborative, learning mindset required to create solutions for patients and their families. To learn more about our efforts to usher in a new generation in medicine, please visit www.generationbio.com or our Twitter feed, @lifetimegeneTX.

keywords:N/A

103

Number of Employees

$16M

Revenue (est)

8

Current Jobs

18%

Employee Growth %

$100M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Tracy ZimmermannVice President, Preclinical Research And Translational BiologyEmail Available
Matthew StantonChief Scientific Officer
Chapman WrightDirector
Carolyn PelletierPrincipal Associate Scientist
Raj EndranAssociate Director
Luckner MilordSenior Director Of It
Robert SilvaAssociate Director, Animal Care Facility
Matthew SimmonsAssociate Director
Will MccarthyChief Business Officer
Birte NoltingSenior Principal Scienstist

Generation Bio News

09/03/2019 - Global & Regional Forecast of Bio Methanol Market from 2019 ...

In the Netherlands, BioMCN converts crude glycerine into advanced second generation bio-methanol. In Canada, bio-methanol is being produced from ...

09/08/2019 - Translate Bio Announces Pipeline Program Update Nasdaq ...

09, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), ... These data are related to the first-generation lipid nanoparticle (LNP) ...

09/03/2019 - Bristol-Meyers Squibb, Boehringer Ingelheim and Other ...

... Next Generation Antibody Screening Technology at Symposia Across the US ... For additional information, please visit www.carterra-bio.com.

Generation Bio Funding

DateAmountRoundLead InvestorsReference
2018-01-09$25.0MAAtlas VentureArticle
2018-02-28$100.0MBFidelity Management & Research CompanyArticle

Generation Bio Executive Hires

DateNameTitleReference
2018-01-09Geoffrey McDonoughPresident/Chief Executive OfficerArticle
2018-04-10Will McCarthyChief Business OfficerArticle
2018-05-09Sara BestenHead of Human ResourcesArticle
2018-11-06Antoinette PaoneHead of Regulatory AffairsArticle
2018-12-18Tom GraneyCFOArticle